Tag | Content |
---|
EnhancerAtlas ID | HS034-09996 |
Organism | Homo sapiens |
Tissue/cell | ECC-1 |
Coordinate | chr15:57939600-57940640 |
| Number of super-enhancer constituents: 7 | ID | Coordinate | Tissue/cell |
SE_00084 | chr15:57936538-57941169 | Adipose_Nuclei | SE_32158 | chr15:57939593-57940314 | Gastric | SE_40619 | chr15:57933581-57941178 | Left_Ventricle | SE_42150 | chr15:57937763-57940338 | Lung | SE_42150 | chr15:57940448-57941140 | Lung | SE_48734 | chr15:57938075-57940314 | Right_Atrium | SE_49546 | chr15:57939679-57940167 | Right_Ventricle |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| Number: 1 | ID | Chromosome | Start | End |
GH15I057646 | chr15 | 57938732 | 57941120 |
|
Enhancer Sequence | TAGGGACGCC TTTATTGCTG TAATGTTTTT CTAAGTCTCT GGTGGAAAAG TCACTGGCAT 60 TTGTTCTAGC AGCATTGATT CATTGCCAAG TTTTAAAAAA GGAAATAATT AAGAGAATGC 120 AATGACCTTT AGAGAAAACA GGTCACCCAT GTAAGTCCTG CTTTCAGGGT GGTGTGCTTT 180 CTTCTGCTTT TAGAGTTTCT TTTCTCTTTT GGGCTATGAA CCGTACCTGG AGGCCAGGCA 240 GGCCTTATTC TGGAGCAGAT AGTGAGTGAG GTTCCTAGAG TACTGCATAG CCTGAGAGTG 300 CCTCCTAAGT GGATGCCCTC CACACCTCCT GCACTTGGCC CTGGCCCTGG GTCCTAGGCT 360 CATTGTTGAT CTTCTTAGAT CTGGGTTCCT TGCATTGCAG GACCTACCTC AGCCTGCTCT 420 TGTCTGCCTT TGCTGATGCC CCTCAATTCA CCTCTTTCCT GCCTGTACTG TGATATGGTG 480 TGAACTTGAC TTATACTGCT TGTGAAACCT GAGTCATGTG CTGAAATCCT GCCCCGCCAC 540 CGCTTTCCTC CCTTAACTGG ATCCTTAGCC TTGGACTCCA AGGCTACAGC TCTGTCTCGT 600 GGCCACTCAA GCCCCACCCA AAGGAGGTGC TACTCAAAAG TTTGAGGCAG GAGTGATTTA 660 TTGTGAATGA CAATGTTATA GTTTCTAATT CTAGTGTTTA GCATGGTATT ATTCCTTATT 720 TATTTTAAAA TCTTAGACAA TTTATCTAAA ATGTCAATTT TTAGAAGGTA TCAGCACAAT 780 TGTGGCAGCC TTTTTTCTGT ATGTGTTATA TGTATTATTT AAAAAAGCAG GTTCATTCTA 840 TGACAGGTAT TGGTTTCGGT ATTCACAATA TAAATTGTCT TTTCAAGGGA AAGGATATTT 900 TCTTTGGAAA TGTCATTGAA TCTATGTTCT CTTTATTGAA ATTGTTCTAA TTGACTTTGA 960 ACTGTTTCTC AGACACCTGG TGCCCAGTTT CTGGCCATAG AAACTATGTG AGGCTGAGTA 1020 ATTCATGTTT TGGGTCACTA 1040
|